After the
Conversation
Provider profile

Invigor Medical

An injectable-care pathway needs a clear clinical support plan and a quote tied to the actual preparation.

After the Conversation Editorial Desk
October 6, 2026 · AI-assisted · Not medically reviewed

The preparation
Provider-reviewed sexual-health care, including compounded Trimix
The advertised price
A current formulation-specific total is needed
Read the conditions
Official help describes practitioner review for refills and an optional subscription for stabilized patients. Complete current price and fees were not established.

Which service is described here?

Invigor Medical's website includes Trimix among its sexual-health treatments and describes provider review before pharmacy shipment. Its official FAQ identifies Trimix as a combination of alprostadil, papaverine and phentolamine administered by injection. This profile describes that pathway without providing injection technique, a dose or a formulation recommendation. [Service overview] [Trimix FAQ]

NIDDK lists injectable medicines among ED treatment approaches. Their place in a menu does not establish that they are appropriate for a particular reader or the required next step after tablets. Discuss the reason for the proposed treatment and alternatives with a qualified clinician. [Treatment options]

What does the refill guidance say?

An official help article dated May 7, 2024 describes a refill request, intake forms and practitioner approval. It also describes a subscription option for patients who have stabilized on a Trimix formulation. Confirm how that published process applies to the current service and individual prescription. [Refill guidance]

The pages reviewed did not establish a complete current formulation-specific price, consultation charge, shipping total or refund arrangement. Ask for those details together. Do not substitute a third-party price estimate or interpret subscription availability as automatic clinical approval for another supply.

What support should be clarified before treatment?

Ask who provides instruction, how medicine storage questions are answered and how to reach clinical help when the response is unexpected. These questions need the treating team and dispensing pharmacy. This publication does not offer a self-injection guide or a home remedy for a prolonged erection.

FDA does not approve compounded drugs. Ingredient descriptions and a provider's efficacy claims do not independently establish the outcomes of a selected compounded formulation. We have not used Invigor's service or verified its advertised ratings. Read the prescription guide for urgent-warning context and reviewing the plan for routine follow-up questions. [FDA]

The references

Accessed October 6, 2026. Provider pages document advertised arrangements; medical and regulatory resources supply general context. Neither implies an endorsement.

  1. Invigor Medical: Services and provider-review pathwayProvider-owned service overview
  2. Invigor Medical: Trimix FAQProvider-owned formulation description; not independent clinical evidence
  3. Invigor Medical: Trimix refill processProvider-owned refill and subscription explanation; May 7, 2024
  4. FDA: Compounding questions and answersRegulatory explanation
  5. NIDDK: Treatment for erectile dysfunctionFederal patient information